← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Dec 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT05906303Overall official - principal investigatorPhase 1Dec 1, 2023
- NCT05906303Lead sponsorPhase 1Dec 1, 2023
- NCT04902950Overall official - principal investigatorPhase 4Aug 17, 2020
- NCT04902950Reponsible party - principal investigatorPhase 4Aug 17, 2020
- NCT04902950Lead sponsorPhase 4Aug 17, 2020
- NCT01110005CollaboratorN/AApr 30, 2010
- NCT00417872Overall official - principal investigatorPhase 2Jan 1, 2004
Details
- Last known activity
- Dec 1, 2023